NanoVibronix Release: UroShield Applied to Urinary Catheters Increases Susceptibility of Bacteria Biofilm to Antibiotic Treatment  
2/8/2012 8:29:15 AM

NESHER, Israel--(BUSINESS WIRE)--NanoVibronix, a medical device company which develops innovative therapeutic ultrasound applications, reported that a study titled “Surface Acoustic Waves Increase the Susceptibility of Pseudomonas Aeruginosa Biofilms to Antibiotic Treatment” has been published in Biofouling by Ehud Banin et al, researchers from the Bar-Ilan University.